Finally, the role of the ERK5 pathway in neoangiogenesis has been evidenced by target depletion of ERK5 in xenograft tumour models of B16F10 melanoma and LL/2 Lewis lung cancer and which resulted in reduced mass and vascular density of the tumours [126]. This evidence concerns the gene MAPK7 and lung carcinoma.